Psoriasis and Cardiovascular Disease: What Patients Need to Know
Why heart disease is the leading cause of death in psoriasis patients: Exploring the link between chronic systemic inflammation and arterial health.
Why Heart Disease Is a Major Concern in Psoriasis
Psoriasis significantly increases the risk of cardiovascular disease, making heart-related conditions the leading cause of death among people with moderate to severe disease. This elevated risk exists even after accounting for traditional factors such as smoking, obesity, and age—pointing to chronic systemic inflammation as the primary driver.
Medical Disclaimer: This content is for informational and educational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any medical condition.
Figure 1: Psoriasis is an inflammatory fire that can spread beyond the skin into the coronary arteries.
🧡 A Warning from a Heart Attack Survivor
As someone who survived a Heart Attack in 2008 and has managed Psoriasis for four years, I understand the invisible link between the two. For years, we thought psoriasis was “just skin.” We now know it is a systemic event.
If you have psoriasis, you aren’t just managing plaques—you are managing your longevity. My goal is to help you catch the warning signs of “Silent Inflammation” before they lead to a cardiac event like mine did. Refer to my Big 6 Pillars of Health to see how I build my vascular safety net.
How Psoriasis Affects the Blood Vessels
Psoriasis triggers persistent immune activation that damages the endothelium—the inner lining of your blood vessels.
Key Cardiovascular Effects:
- Accelerated Atherosclerosis: The hardening of arteries occurs earlier and more aggressively.
- Increased Arterial Stiffness: Reducing the efficiency of the heart’s output.
- Plaque Instability: Inflammatory cytokines (TNF-α, IL-17) can make arterial plaques “soft” and more likely to rupture, causing a heart attack.
The Role of Metabolic Syndrome
The same insulin resistance that complicates psoriasis is now being linked to Cognitive Decline—a concept researchers call Type 3 Diabetes. When psoriasis and metabolic syndrome overlap, they create a “perfect storm” of accelerated vascular damage.
đź“‹ The Psoriasis-Heart Advocacy Checklist
Take these three questions to your next physical to ensure your heart is being monitored as closely as your skin:
- hs-CRP Test: “Can we check my High-Sensitivity C-Reactive Protein? It’s a key marker for the systemic inflammation driving my psoriasis.”
- Calcium Scoring: “Given my history of autoimmune inflammation, should we perform a Heart Scan (CAC) to check for silent plaque?”
- Integrated Care: “Does my cardiologist know my psoriasis is active? We need to coordinate my lipid management with my inflammatory flares.”
🎯 March 2026 Clinical Update: Resilience Targets
- Vascular Integrity: Maintain a systemic blood pressure of <130/80 mmHg to reduce the “pounding” effect of high pressure on inflamed vessels.
- Protein Support: To maintain skin cell turnover and lean muscle mass during systemic therapy, seniors must target 1.2–1.6 g/kg of high-quality protein (USDA 2026).
- Treatment Note: Recent VASCULAR trials suggest that biologic therapies (like TNF-inhibitors) can actually reduce the volume of dangerous “soft” coronary plaque.
About the Researcher
Tommy T. Douglas is an independent health researcher and patient advocate. A survivor of a major heart attack who manages Type 2 Diabetes, he specializes in translating complex cardiovascular data into actionable health literacy.
🧩 Clinical Research Glossary
Medical References
- Mehta NN, et al. Psoriasis and cardiovascular disease. JAMA.
- Gelfand JM, et al. Risk of myocardial infarction in psoriasis. JAMA.
- Boehncke WH, et al. Psoriasis and atherosclerosis. Lancet.